Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2023
About
Suggestions
Contact Us
motavizumab
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
motavizumab
Unique ID
C506968
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C506968
Entry Term(s)
MEDI-524
Numax
Registry Number
50Y163LK8Q
Previous Indexing
*ANIBODIES, MONOCLONAL (2006-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
41
Note
is a MAb derived from palivizumab with enhanced neutralizing activity against RSV
Source
Antimicrob Agents Chemother. 2005 Nov;49(11):4700-7
Date of Entry
2006/01/13
Revision Date
2019/10/31
Expand All
Collapse All
motavizumab
Preferred
Concept UI
M0535759
Registry Number
50Y163LK8Q
Terms
motavizumab
Preferred Term
Term UI
T751462
Date
05/18/2009
LexicalTag
NON
ThesaurusID
Numax
Narrower
Concept UI
M0495651
Registry Number
0
Terms
Numax
Preferred Term
Term UI
T664297
Date
01/13/2006
LexicalTag
TRD
ThesaurusID
NLM (2006)
MEDI-524
Narrower
Concept UI
M0493909
Registry Number
0
Terms
MEDI-524
Preferred Term
Term UI
T794403
Date
07/28/2011
LexicalTag
LAB
ThesaurusID
NLM (2011)
page delivered in 0.004s